Activating STING1-dependent immune signaling in TP53 mutant and wild-type acute myeloid leukemia.
Saved in:
| Title: | Activating STING1-dependent immune signaling in TP53 mutant and wild-type acute myeloid leukemia. |
|---|---|
| Authors: | Kogan AA; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201.; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201., Topper MJ; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231., Dellomo AJ; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201.; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201., Stojanovic L; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201.; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201., McLaughlin LJ; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201.; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201., Creed TM; Center for Stem Cell Biology and Regenerative Medicine, University of Maryland School of Medicine, Baltimore, MD 21201., Eberly CL; Center for Stem Cell Biology and Regenerative Medicine, University of Maryland School of Medicine, Baltimore, MD 21201., Kingsbury TJ; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201.; Center for Stem Cell Biology and Regenerative Medicine, University of Maryland School of Medicine, Baltimore, MD 21201.; Department of Physiology, University of Maryland School of Medicine, Baltimore, MD 21201., Baer MR; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201., Kessler MD; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231., Baylin SB; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231.; Van Andel Research Institute, Grand Rapids, MI 49503., Rassool FV; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201.; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201. |
| Source: | Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Jul 05; Vol. 119 (27), pp. e2123227119. Date of Electronic Publication: 2022 Jun 27. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
